Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
28.00
-1.05 (-3.61%)
At close: Sep 25, 2026, 4:00 PM EDT
27.91
-0.09 (-0.32%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Faeth Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
723.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Geron | 204.56M |
| 4D Molecular Therapeutics | 92.01M |
| Inventiva | 7.94M |
| Attovia Therapeutics | 1.80M |
| Avalo Therapeutics | 59.00K |
FTH News
- 8 days ago - Faeth Therapeutics names Karen Vousden to board of directors - TheFly
- 8 days ago - Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors - Business Wire
- 9 days ago - Faeth Therapeutics initiated with a Buy at Guggenheim ahead of de-risking data - TheFly
- 10 days ago - Faeth Therapeutics initiated with a Buy at Guggenheim - TheFly
- 11 days ago - Faeth Therapeutics assumed with a Buy at Lucid Capital - TheFly
- 16 days ago - Faeth Therapeutics initiated with a Buy at TD Cowen - TheFly
- 17 days ago - Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire
- 24 days ago - Faeth Therapeutics to Participate in Upcoming September Investor Conferences - Business Wire